Jaime Eberle

Title: Innovations of Jaime Eberle

Introduction

Jaime Eberle is an accomplished inventor based in Delmar, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic methods. With a total of three patents to his name, Eberle's work focuses on enhancing the efficacy of treatments for cancer.

Latest Patents

Eberle's latest patents include groundbreaking inventions related to exotoxin A. One of his notable inventions is an exotoxin A (PE) that comprises an amino acid sequence with substitutions of one or more B-cell and/or T-cell epitopes. This invention also encompasses related chimeric molecules, nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions. Furthermore, the patent outlines methods for treating or preventing cancer in mammals, inhibiting the growth of target cells, and producing both the PE and the chimeric molecule.

Career Highlights

Jaime Eberle is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to contribute to vital research that has the potential to impact public health significantly.

Collaborations

Eberle has collaborated with notable colleagues in his field, including Ira H Pastan and Ronit Mazor. These collaborations have likely enriched his research and contributed to the advancement of his innovative projects.

Conclusion

Jaime Eberle's contributions to biotechnology through his patents and research at the National Institutes of Health highlight his commitment to improving cancer treatment methods. His innovative work continues to pave the way for advancements in medical science.